Co-administration of ramelton and fluvoxamine to increase levels of interleukin-2

Medical Hypotheses

Volumn 67, Issue 6, 2006, Pages 1389-1390

  Kast, Richard E ^a   Altschuler, Eric Lewin ^b  

^a UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

^b RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME P450 1A2; FLUVOXAMINE; INTERLEUKIN 2; MELATONIN 1 RECEPTOR; MELATONIN 2 RECEPTOR; MELATONIN DERIVATIVE; RAMELTON; UNCLASSIFIED DRUG;

ANTIVIRAL ACTIVITY; ARTICLE; CYTOKINE PRODUCTION; DRUG APPROVAL; DRUG BLOOD LEVEL; DRUG DOSE REGIMEN; FOOD AND DRUG ADMINISTRATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; IMMUNOSTIMULATION; INSOMNIA; MAINTENANCE THERAPY; METASTASIS; METASTASIS INHIBITION; OBSESSIVE COMPULSIVE DISORDER; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION;

ADJUVANTS, IMMUNOLOGIC; ADMINISTRATION, ORAL; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; CYTOCHROME P-450 CYP1A2; DRUG COMBINATIONS; FLUVOXAMINE; HUMANS; INTERLEUKIN-2; LIVER; LYMPHOCYTES; MELATONIN; MODELS, BIOLOGICAL; RECEPTORS, MELATONIN;

EID: 33748967926     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mehy.2006.05.050     Document Type: Article

References (4)

1. FDA labelling information [online]. Available from: http://www.fda.gov/cder/foi/label/2005/021782lbl.pdf; 2005.
2. Pozo D., et al. Expression of the Mel1a-melatonin receptor mRNA in T and B subsets of lymphocutes from rat thymus and spleen. FASEB J 11 (1997) 466-473
3. 2 receptor agonist. Neuropharmacology 28 (2005) 301-310
4. Carrillo-Vico A., et al. Human lymphocyte-synthesized melatonin is involved in the regulation of the interleukin-2/interleukin-2 receptor system. J Clin Endocr Metab 90 (2005) 992-1000